Translational Development Acquisition Corp. (TDACU) Operating Expenses (2023 - 2026)
Translational Development Acquisition's (TDACU) quarterly Operating Expenses came in at $281161.0 in Q1 2026, down 19.07% YoY from $347408.0 in Q1 2025, and up 73.19% on a QoQ basis from $162345.0 in Q4 2025.
Translational Development Acquisition Corp. (TDACU) Operating Expenses (2023 - 2026) Analysis & Trends
Translational Development Acquisition (TDACU) has 4 years of Operating Expenses data on file, last reported at $281161.0 in Q1 2026.
- Quarterly Operating Expenses fell 19.07% year-over-year to $281161.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $878291.0 (down 14.53% YoY) and the FY2025 annual result came in at $944538.0, up 381.03% from the prior year.
- Operating Expenses improved to $281161.0 in Q1 2026, from $162345.0 in the prior quarter.
- In the past five years, Operating Expenses ranged from a high of $485550.0 in Q4 2023 to a low of $61283.0 in Q3 2024.
- A 4-year average of $238240.2 and a median of $217392.5 in 2025 frame the typical range for Operating Expenses.
- Annual changes were most pronounced in 2024 — Operating Expenses slumped 72.53% — and 2025, when it soared 248.64%.
- Tracing TDACU's Operating Expenses over 4 years: stood at $485550.0 in 2023, then tumbled by 72.53% to $133390.0 in 2024, then climbed by 21.71% to $162345.0 in 2025, then jumped by 73.19% to $281161.0 in 2026.
- The last three Operating Expenses figures came in at $281161.0 (Q1 2026), $162345.0 (Q4 2025), and $213658.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 281,161.00 |
| Dec 31, 2025 | 162,345.00 |
| Sep 30, 2025 | 213,658.00 |
| Jun 30, 2025 | 221,127.00 |
| Mar 31, 2025 | 347,408.00 |
| Dec 31, 2024 | 133,390.00 |
| Sep 30, 2024 | 61,283.00 |
| Dec 31, 2023 | 485,550.00 |